Racial and ethnic disparities in telehealth access for schizophrenia patients reveal broader inequities in mental health care ...

Key barriers include misdiagnosis, insufficient gMG knowledge among healthcare providers, and limited access to specialists, ...

Here are the top 5 AJMC.com articles and videos on allergy for 2025.

New research is helping shed light on the ways chronic inducible cold urticaria (ColdU) can affect the daily lives of ...

Here are the top IVBM articles from 2025 capturing how value-based strategies are translating into real-world impact. Click ...

Lisocabtagene maraleucel (liso-cel) shows high response rates in heavily pretreated patients with relapsed or refractory chronic lymphocytic leukemia (CLL), with a CR/CRu rate of 60% and ORR of 83.3%.

Baricitinib was generally well-tolerated. Acne was the most common adverse event (17.6%), followed by dyslipidemia (7.8%). Asthenia, elevated liver enzymes, and weight gain each occurred in fewer than ...

An in-home, exergame-based step training program did not improve ankle proprioception or plantarflexor muscle performance in people with multiple sclerosis (MS), according to a secondary outcomes ...

Our top 5 heart failure articles of 2025 include FDA approvals, improving guideline-directed medical therapy (GDMT), markers ...

To wrap up this year's author podcast series, The American Journal of Managed Care® speaks with Angela Liu, PhD, MPH, ...

The FDA has approved the first oral glucagon-like peptide-1 (GLP-1) receptor agonist for weight loss and to reduce the risk ...

Achieving equitable access to anti-fibrotic drugs requires multi-stakeholder collaboration, while the most critical unmet ...